Real Estate

MILAN, Sept 30 (Reuters) - Statement by UniCredit SpA on disposal of real estate portfolio to Ream fund on Wednesday:
* disposes of real estate portfolio to closed Ream fund for about 574 mln euro ($836.3 million)
* Majority stake in fund sold to investors named by Ream
* Capital gain on sale about 110 mln euros in Q3
(Reporting by Elisabetta Andreis, reporting by Ian Simpson)
($1=.6863 Euro) Keywords: UNICREDIT/REALESTATE

(ian.simpson@reuters.com; +39 02 6612 9666; Reuters Messaging: ian.simpson@reuters.com@reuters.net)

COPYRIGHT

Copyright Thomson Reuters 2009. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

WASHINGTON (AP) — A bipartisan push is under way in the Senate to spend more money to stop mortgage scams.

Sens. Charles Schumer, a Democrat, and Jon Kyl, a Republican, proposed legislation on Tuesday that would award up to $200 million to state and local prosecutors to go after real estate fraud.

The money would be awarded as competitive grants to prosecutors’ offices to hire new investigators, accountants and attorneys. Advocates say states have been unable to prosecute many troubling cases because of a lack of staff and other resources.

“The housing crisis has spawned a cottage industry of refinancing and foreclosure prevention scams,” Schumer said in a statement. “This bill will put a stop to the criminals who are trying to swoop in and take advantage of desperate homeowners.”

As a New York senator, Schumer represents Wall Street but has championed such politically popular issues as reducing foreclosure rates.

Kyl, a conservative, has taken up consumer rights issues such as identify theft. His home state of Arizona has experienced some of the highest foreclosure rates in the country.

Their legislative proposal represents a rare show of bipartisanship in a Congress divided on President Barack Obama’s plan to rewrite the rules governing financial institutions.

Democrats are advocating the creation of a new agency dedicated to consumer protections. Republicans oppose it, saying the measure would be too burdensome on banks.

Posted by: Prashant Gopal on September 29

We spend a lot of time here on the HotProperty blog gauging the health of the real estate market and pointing to clues about where it might be heading.

But today, we need your help. Tell us about the nagging questions you have about the housing market (example: How hard it really is to get a loan or what’s the best way to go about securing one? What might a housing recovery look like? Is this a good time to buy an investment property?)

We’ll collect the best questions and try to answer them in a week or two. No question is too small. But we’ll be looking to answer questions that will be helpful to a large number of readers and, preferably, haven’t been answered in previous stories.

So send questions early and often to prashant_gopal@businessweek.com. We’ve closed the comments on this post because we’d like you to e-mail us directly. If you’d like your name to be included in the story, please send it to us along with a phone number where we can reach you during the day.

Look forward to hearing from you.

UPDATE:
Thanks to those who have already sent in questions. One request, try to word your questions in a way that they’re relevant to a larger audience. In other words, rather than spelling out your personal housing situation, ask me a broader question. Here’s an example of a great question we received: Does the traditional rule of thumb that housing shouldn’t cost more than 2.5 times annual income still apply today?

Keep the questions coming!

67 WALL STREET, New York – September 28, 2009 – The Wall Street Transcript has just published its Medical Real Estate: Healthcare REITs, Long-Term Care Facilities and Hospitals Report offering a timely review of the sector to serious investors and industry executives. This 45 page feature contains expert industry commentary through 10 in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Topics covered: Investor Perception of Medical Facilities Publicly Traded Securities — Shift from Inpatient to Outpatient Care — Economic Implications of Health Care Reform — Medical REITs Growth — Public Markets Reaction to Obamacare Proposals — Sustainability of Dividend Yields In Different Health Care Legislation Scenarios — Ability to Access Debt Capital — Implication of Aging Population — Profits of Outpatient Versus Inpatient Care — Health Care Delivery Costs — Leaseback Arrangements — Skilled Nursing Costs — Growth of Seniors Housing — Geographical Analysis for Profits in Medical Real Estate — Advantages to Investing in Licensed Hospitals — Access to Equity Underwriting — Economics of a Fragmented Industry — Consolidation Opportunities — Debt Refinancing Strategies — Mergers and Acquisitions in the Medical Facilities Industry

Companies include: LifePoint Hospitals (LPNT); Community Health Systems (CYH); Psychiatric Solutions (PSYS) and Tenet (THC); Medical Properties Trust (MPW); Healthcare Realty Trust (HR); LTC Properties (LTC); Health Care REIT (HCN); National Health Investors (NHI); HCP Inc. (HCP); Alexandria (ARE); BioMed (BMR); Senior Housing Properties Trust (SNH); Omega Healthcare Investors (OHI); Ventas (VTR); Emeritus (ESC); Brookdale (BKO); Fannie Mae (FNM); US Physical Therapy (USPH); AmSurg (AMSG)

In the following brief excerpt from just one of the 10 interviews in the 45 page report, Stifel Nicolaus Industry Expert Jerry Doctrow discusses the outlook for the sector and for investors.

Jerry L. Doctrow is a Managing Director of Stifel, Nicolaus & Co., and he leads the firm’s six-person health care services and health care real estate research team. He has been recognized six times by The Wall Street Journal and twice by Forbes/Starmine as one of the best health care or real estate analysts in the U.S. Mr. Doctrow and his team follow 45 publicly traded companies, including 11 health care REITs. Mr. Doctrow has over 30 years’ experience in equity research, consulting, public policy, finance and market analysis. He spent 18 years at Legg Mason, where he led the health care services research team and served as President of the firm’s real estate consulting unit, advising not-for-profit and corporate clients on the development of senior housing and health care facilities. Stifel Nicolaus acquired Legg Mason’s capital markets division in December 2005. Mr. Doctrow served on the board of a not-for-profit agency that developed several hundred units of senior housing and, together with members of his family, has selected and monitored assisted living and nursing facilities for his own parents. He spent his early career in the public sector as an urban planner and housing finance program administrator. Mr. Doctrow has a B.A. in social and behavioral science from Johns Hopkins University, and a master’s in public administration from George Washington University. He is an Associate on the faculty of the Department of Health Policy and Management at the Johns Hopkins University Bloomberg School of Public Health; he has also advised researchers at the World Bank on using private investment to improve health care delivery in developing countries. Mr. Doctrow is a frequent speaker at industry conferences. He leads an annual conference on senior housing and health care real estate that features CEOs from all of the public senior housing providers and health care REITs, and co-chairs the Stifel Nicolaus/Johns Hopkins annual health policy symposium, which this year focused on “The Tangible Impacts of Healthcare Reform.” His recent publications include Healthcare REITs – Antidote for an Economic Downturn?, published in the winter of 2008.

TWST: Would you include biotech or life sciences properties in the broad “health care” label?

Mr. Doctrow: Yes, the largest health care REIT, HCP (HCP), has a significant life science portfolio. And there’s two dedicated life science REITs, Alexandria (ARE), that we do not cover, and a company called BioMed (BMR), that one of my colleagues covers. I used to cover it actually. What we found is that for whatever reason, investors tend to group life science REITs with office and industrial companies. So John Guinee, our office analyst, covers BioMed for us. I can give you a couple thoughts in general about what’s going on with life science. I think if you went back even just a few years, you would have seen a very attractive real estate class. Biotech was obviously a significant industry; it was growing rapidly. It’s concentrated in a relatively small number of markets in the U.S. – on the West Coast, San Francisco, San Diego, Seattle; on the East Coast, Boston, number one, D.C. and then a belt of life science real estate in New York/central New Jersey, the traditional center of the pharma industry. Almost all life science assets-people invest in are in one of those six markets. And it’s very specialized real estate, so if you have expertise in it, you really have an established niche. It is not like somebody that does apartments is going to start building life science or even someone that builds general office; there are a lot of special aspects to it. I think, over the last year or so, because life science is very dependent on the equity capital markets, debt markets, private equity markets, there’s been more uncertainty as to where the capital is coming from for that industry. So uncertainty in the capital markets has raised more questions in peoples’ minds. What seems to be happening from a global standpoint is Big Pharma, to some extent, is stepping in and being another source of capital to sustain that industry, the best example being Roche buying Genentech. So I think people, after being a little nervous, are feeling somewhat better about it but still keeping an eye on where the capital markets, where the economy are going to settle out. And some life science real estate REITs have been involved in a lot of development, which is, just in general, an area that creates a little bit more uncertainty for investors today. I think it’s an interesting asset class. HCP is a way to invest in life science real estate as well as other health care real estate. And it’s probably the best stock to play kind of a cross-section of all health care sectors because it’s the most diversified, while the other two players in life science are really specialized just in that space, and other health care REITs are more focused on only one or two other health care real estate sectors.

The Wall Street Transcript is a unique service for investors and industry researchers – providing fresh commentary and insight through verbatim interviews with CEOs and research analysts. This 45 page special issue is available by calling (212) 952-7433 or via
The Wall Street Transcript Online
.

The Wall Street Transcript does not endorse the views of any interviewees nor does it make stock recommendations.

For Information on subscribing to The Wall Street Transcript, please call 800/246-7673

67 WALL STREET, New York – September 28, 2009 – The Wall Street Transcript has just published its Medical Real Estate: Healthcare REITs, Long-Term Care Facilities and Hospitals Report offering a timely review of the sector to serious investors and industry executives. This 45 page feature contains expert industry commentary through 10 in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Topics covered: Investor Perception of Medical Facilities Publicly Traded Securities — Shift from Inpatient to Outpatient Care — Economic Implications of Health Care Reform — Medical REITs Growth — Public Markets Reaction to Obamacare Proposals — Sustainability of Dividend Yields In Different Health Care Legislation Scenarios — Ability to Access Debt Capital — Implication of Aging Population — Profits of Outpatient Versus Inpatient Care — Health Care Delivery Costs — Leaseback Arrangements — Skilled Nursing Costs — Growth of Seniors Housing — Geographical Analysis for Profits in Medical Real Estate — Advantages to Investing in Licensed Hospitals — Access to Equity Underwriting — Economics of a Fragmented Industry — Consolidation Opportunities — Debt Refinancing Strategies — Mergers and Acquisitions in the Medical Facilities Industry

Companies include: LifePoint Hospitals (LPNT); Community Health Systems (CYH); Psychiatric Solutions (PSYS) and Tenet (THC); Medical Properties Trust (MPW); Healthcare Realty Trust (HR); LTC Properties (LTC); Health Care REIT (HCN); National Health Investors (NHI); HCP Inc. (HCP); Alexandria (ARE); BioMed (BMR); Senior Housing Properties Trust (SNH); Omega Healthcare Investors (OHI); Ventas (VTR); Emeritus (ESC); Brookdale (BKO); Fannie Mae (FNM); US Physical Therapy (USPH); AmSurg (AMSG)

In the following brief excerpt from just one of the interviews in the 45 page report, Stifel Nicolaus Industry Expert Jerry Doctrow discusses the outlook for the sector and for investors.

Jerry L. Doctrow is a Managing Director of Stifel, Nicolaus & Co., and he leads the firm’s six-person health care services and health care real estate research team. He has been recognized six times by The Wall Street Journal and twice by Forbes/Starmine as one of the best health care or real estate analysts in the U.S. Mr. Doctrow and his team follow 45 publicly traded companies, including 11 health care REITs. Mr. Doctrow has over 30 years’ experience in equity research, consulting, public policy, finance and market analysis. He spent 18 years at Legg Mason, where he led the health care services research team and served as President of the firm’s real estate consulting unit, advising not-for-profit and corporate clients on the development of senior housing and health care facilities. Stifel Nicolaus acquired Legg Mason’s capital markets division in December 2005. Mr. Doctrow served on the board of a not-for-profit agency that developed several hundred units of senior housing and, together with members of his family, has selected and monitored assisted living and nursing facilities for his own parents. He spent his early career in the public sector as an urban planner and housing finance program administrator. Mr. Doctrow has a B.A. in social and behavioral science from Johns Hopkins University, and a master’s in public administration from George Washington University. He is an Associate on the faculty of the Department of Health Policy and Management at the Johns Hopkins University Bloomberg School of Public Health; he has also advised researchers at the World Bank on using private investment to improve health care delivery in developing countries. Mr. Doctrow is a frequent speaker at industry conferences. He leads an annual conference on senior housing and health care real estate that features CEOs from all of the public senior housing providers and health care REITs, and co-chairs the Stifel Nicolaus/Johns Hopkins annual health policy symposium, which this year focused on “The Tangible Impacts of Healthcare Reform.” His recent publications include Healthcare REITs – Antidote for an Economic Downturn?, published in the winter of 2008.

TWST: Would you include biotech or life sciences properties in the broad “health care” label?

Mr. Doctrow: Yes, the largest health care REIT, HCP (HCP), has a significant life science portfolio. And there’s two dedicated life science REITs, Alexandria (ARE), that we do not cover, and a company called BioMed (BMR), that one of my colleagues covers. I used to cover it actually. What we found is that for whatever reason, investors tend to group life science REITs with office and industrial companies. So John Guinee, our office analyst, covers BioMed for us. I can give you a couple thoughts in general about what’s going on with life science. I think if you went back even just a few years, you would have seen a very attractive real estate class. Biotech was obviously a significant industry; it was growing rapidly. It’s concentrated in a relatively small number of markets in the U.S. – on the West Coast, San Francisco, San Diego, Seattle; on the East Coast, Boston, number one, D.C. and then a belt of life science real estate in New York/central New Jersey, the traditional center of the pharma industry. Almost all life science assets-people invest in are in one of those six markets. And it’s very specialized real estate, so if you have expertise in it, you really have an established niche. It is not like somebody that does apartments is going to start building life science or even someone that builds general office; there are a lot of special aspects to it. I think, over the last year or so, because life science is very dependent on the equity capital markets, debt markets, private equity markets, there’s been more uncertainty as to where the capital is coming from for that industry. So uncertainty in the capital markets has raised more questions in peoples’ minds. What seems to be happening from a global standpoint is Big Pharma, to some extent, is stepping in and being another source of capital to sustain that industry, the best example being Roche buying Genentech. So I think people, after being a little nervous, are feeling somewhat better about it but still keeping an eye on where the capital markets, where the economy are going to settle out. And some life science real estate REITs have been involved in a lot of development, which is, just in general, an area that creates a little bit more uncertainty for investors today. I think it’s an interesting asset class. HCP is a way to invest in life science real estate as well as other health care real estate. And it’s probably the best stock to play kind of a cross-section of all health care sectors because it’s the most diversified, while the other two players in life science are really specialized just in that space, and other health care REITs are more focused on only one or two other health care real estate sectors.

The Wall Street Transcript is a unique service for investors and industry researchers – providing fresh commentary and insight through verbatim interviews with CEOs and research analysts. This 45 page special issue is available by calling (212) 952-7433 or via
The Wall Street Transcript Online
.

The Wall Street Transcript does not endorse the views of any interviewees nor does it make stock recommendations.

For Information on subscribing to The Wall Street Transcript, please call 800/246-7673

67 WALL STREET, New York – September 28, 2009 – The Wall Street Transcript has just published its Medical Real Estate: Healthcare REITs, Long-Term Care Facilities and Hospitals Report offering a timely review of the sector to serious investors and industry executives. This 45 page feature contains expert industry commentary through 10 in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Topics covered: Investor Perception of Medical Facilities Publicly Traded Securities — Shift from Inpatient to Outpatient Care — Economic Implications of Health Care Reform — Medical REITs Growth — Public Markets Reaction to Obamacare Proposals — Sustainability of Dividend Yields In Different Health Care Legislation Scenarios — Ability to Access Debt Capital — Implication of Aging Population — Profits of Outpatient Versus Inpatient Care — Health Care Delivery Costs — Leaseback Arrangements — Skilled Nursing Costs — Growth of Seniors Housing — Geographical Analysis for Profits in Medical Real Estate — Advantages to Investing in Licensed Hospitals — Access to Equity Underwriting — Economics of a Fragmented Industry — Consolidation Opportunities — Debt Refinancing Strategies — Mergers and Acquisitions in the Medical Facilities Industry

Companies include: LifePoint Hospitals (LPNT); Community Health Systems (CYH); Psychiatric Solutions (PSYS) and Tenet (THC); Medical Properties Trust (MPW); Healthcare Realty Trust (HR); LTC Properties (LTC); Health Care REIT (HCN); National Health Investors (NHI); HCP Inc. (HCP); Alexandria (ARE); BioMed (BMR); Senior Housing Properties Trust (SNH); Omega Healthcare Investors (OHI); Ventas (VTR); Emeritus (ESC); Brookdale (BKO); Fannie Mae (FNM); US Physical Therapy (USPH); AmSurg (AMSG)

In the following brief excerpt from just one of the interviews in the 45 page report, Stifel Nicolaus Industry Expert Jerry Doctrow discusses the outlook for the sector and for investors.

Jerry L. Doctrow is a Managing Director of Stifel, Nicolaus & Co., and he leads the firm’s six-person health care services and health care real estate research team. He has been recognized six times by The Wall Street Journal and twice by Forbes/Starmine as one of the best health care or real estate analysts in the U.S. Mr. Doctrow and his team follow 45 publicly traded companies, including 11 health care REITs. Mr. Doctrow has over 30 years’ experience in equity research, consulting, public policy, finance and market analysis. He spent 18 years at Legg Mason, where he led the health care services research team and served as President of the firm’s real estate consulting unit, advising not-for-profit and corporate clients on the development of senior housing and health care facilities. Stifel Nicolaus acquired Legg Mason’s capital markets division in December 2005. Mr. Doctrow served on the board of a not-for-profit agency that developed several hundred units of senior housing and, together with members of his family, has selected and monitored assisted living and nursing facilities for his own parents. He spent his early career in the public sector as an urban planner and housing finance program administrator. Mr. Doctrow has a B.A. in social and behavioral science from Johns Hopkins University, and a master’s in public administration from George Washington University. He is an Associate on the faculty of the Department of Health Policy and Management at the Johns Hopkins University Bloomberg School of Public Health; he has also advised researchers at the World Bank on using private investment to improve health care delivery in developing countries. Mr. Doctrow is a frequent speaker at industry conferences. He leads an annual conference on senior housing and health care real estate that features CEOs from all of the public senior housing providers and health care REITs, and co-chairs the Stifel Nicolaus/Johns Hopkins annual health policy symposium, which this year focused on “The Tangible Impacts of Healthcare Reform.” His recent publications include Healthcare REITs – Antidote for an Economic Downturn?, published in the winter of 2008.

TWST: Would you include biotech or life sciences properties in the broad “health care” label?

Mr. Doctrow: Yes, the largest health care REIT, HCP (HCP), has a significant life science portfolio. And there’s two dedicated life science REITs, Alexandria (ARE), that we do not cover, and a company called BioMed (BMR), that one of my colleagues covers. I used to cover it actually. What we found is that for whatever reason, investors tend to group life science REITs with office and industrial companies. So John Guinee, our office analyst, covers BioMed for us. I can give you a couple thoughts in general about what’s going on with life science. I think if you went back even just a few years, you would have seen a very attractive real estate class. Biotech was obviously a significant industry; it was growing rapidly. It’s concentrated in a relatively small number of markets in the U.S. – on the West Coast, San Francisco, San Diego, Seattle; on the East Coast, Boston, number one, D.C. and then a belt of life science real estate in New York/central New Jersey, the traditional center of the pharma industry. Almost all life science assets-people invest in are in one of those six markets. And it’s very specialized real estate, so if you have expertise in it, you really have an established niche. It is not like somebody that does apartments is going to start building life science or even someone that builds general office; there are a lot of special aspects to it. I think, over the last year or so, because life science is very dependent on the equity capital markets, debt markets, private equity markets, there’s been more uncertainty as to where the capital is coming from for that industry. So uncertainty in the capital markets has raised more questions in peoples’ minds. What seems to be happening from a global standpoint is Big Pharma, to some extent, is stepping in and being another source of capital to sustain that industry, the best example being Roche buying Genentech. So I think people, after being a little nervous, are feeling somewhat better about it but still keeping an eye on where the capital markets, where the economy are going to settle out. And some life science real estate REITs have been involved in a lot of development, which is, just in general, an area that creates a little bit more uncertainty for investors today. I think it’s an interesting asset class. HCP is a way to invest in life science real estate as well as other health care real estate. And it’s probably the best stock to play kind of a cross-section of all health care sectors because it’s the most diversified, while the other two players in life science are really specialized just in that space, and other health care REITs are more focused on only one or two other health care real estate sectors.

The Wall Street Transcript is a unique service for investors and industry researchers – providing fresh commentary and insight through verbatim interviews with CEOs and research analysts. This 45 page special issue is available by calling (212) 952-7433 or via
The Wall Street Transcript Online
.

The Wall Street Transcript does not endorse the views of any interviewees nor does it make stock recommendations.

For Information on subscribing to The Wall Street Transcript, please call 800/246-7673

Following are real estate transactions over $5,000 as listed in records of the Niagara County clerk’s office for the week ending Aug. 14.

CAMBRIA

• 3245 Andrews Road, Joseph A. Berti to Jeffrey L. Blickenstaff; Karen A. Blickenstaff, $195,000.

• Joanne Drive, Charles J. Parker; Christine M. Parker to Raymond J. Miller, $155,200.

• 5177 Lower Mountain Road, B. Jill Bebee; Harold D. Campbell to Craig C. Miller, $150,000.

• 5177 Lower Mountain Road, B. Jill Bebee; Harold D. Campbell to Craig C. Miller, $80,000.

• Willow Creek Lane, Castleton Development Llc to Ryan Homes of New York; Nvr Inc., $31,000.

HARTLAND

• Hartland St.,FMC Corp. to Robert A. Webster, $37,000.

LEWISTON

• Raymond Drive, Joseph W. Davignon to Julie Siegel; Christopher D. Siegel, $266,900.

• Aberdeen Road, Terry J. Garner; Martha A. Garner to Susan K. Stanton, $235,000.

• Lower River Road, Robert E. Levitt to Robert T. Koryl; Patricia M. Koryl, $230,000.

• Sara Court, Susan K. Stanton; Mark E. Stanton to John M. Maslany; Pamela S. Maslany, $229,900.

• Hewitt Parkway, Robert M. Stefik; David W. Stefik to Robert M. Stefik; William A. Stefik, $203,000.

• Scovell Drive, Michele A. Davolio; David E. Davolio to Rosemary A. Sperrazza; John J. Sperrazza, $166,000.

• North Water St., Colleen Kaczmarek; Richard J. Freise to Mark Finn; Laurie Finn, $80,000.

• Riverwalk Drive, Lewiston-Porter Development Llc to Ryan Homes of New York; Nvr Inc., $32,500.

LOCKPORT

• Continental Drive, Ray W. Weidman to David Keleher; Dawn M. Glinski, $141,960.

• 16 Blackley Court, James Vasiliou to Fannie Mae, $93,216.

• 263 North Transit St., Michelle S. Dsouza to Fannie Mae, $56,519.

• William St., Lance Kutrybala to Thomas Dumais, $28,000.

• East Genessee St., Saul Glazer; Paul Glazer to Steven F. Cutter; Linda M. Cutter, $10,000.

TOWN OF LOCKPORT

• Brian Walk&Emily Lane, Robert W. Brooks; Susan M. Brooks to Lindsay M. Knox; David S. Knox, $175,000.

• 6475 Rapids Road, Robert Locicero; Roselily Locicero to HSBC Bank, $172,503.

• North View Drive, Tracy A. Sikorski-Therrien; Bernie J. Therrien to Philip A. Johengen; Michele E. Johengen, $95,500.

• Akron Road, Kimberly Burton; Parris Burton to Matthew P. Kukulka; Jillian D. Kukulka, $68,000.

• Lake Ave., New Directions Youth and Family Services Inc. to Niagara County Extension Service Association, $55,000.

TOWN OF NIAGARA

• Beechwood Circle, Ronald K. Jones; Lena J. Jones to Edward Larocque; Yvonne Larocque, $158,000.

NIAGARA FALLS

• Mason Court, Mary Anne Benton; Allen V. Benton Sr. to Nicole C. Schug, $105,000.

• 90th St., Dorothy J. Jones; Daniel R. Jones to David R. Stoll, $95,500.

• Jerauld Ave., Dawn M. Elledge; Kevin J. Elledge to Dean Tamborello, $87,500.

• 1116 Roselle Ave., Sylvia Ziehm to Wells Fargo Bank, $73,358.

• 83rd St., Kathryn Neville; Paul Kloosterman; Patricia Kloosterman; William Kloosterman; Jon R. Kloosterman; John R. Kloosterman to Terry L. Equils; Marian R. Equils, $73,000.

• 68th St., Catherine A. Allen to Sherry Sczepczenski; Julia Sczepczenski, $63,000.

• 3rd St.&Buffalo Ave. Parkway Condo Unit 511, Anthony Cristofanelli; Emma M. Kotlarz; Benjamin J. Kotlarz; Michael Cristofanelli to Elbouri Amira; Hesham Eltagouri, $60,000.

• Welch Ave., Rose Kochanski to April M. Anthony, $55,900.

• Deveaux St., Marion Bordin; Leo Bordin to Nichole Shanor, $52,500.

• Main St., Choon E. Yu to Sanil B. Nigalye, $50,000.

• 28th St., Debra Lynn Roscetti; Betty Ann Roscetti-Brown; James C. Roscetti to Alan J. Roscetti, $46,600.

• Cedar Ave., Tobetto Realty Inc. to Absolute Best Properties Llc, $43,500.

• McKoon Ave., Antonette Cerra; Joseph A. Cerra to Annette Michael-Kasper, $39,900.

• 1256 93rd St., Audrey Marie Kurtis; Audrey J. Kurtis; Brian A. Kurtis; Anne M. Kurtis to Brian A. Kurtis, $36,900.

• McKoon Ave., Guy E. Bender to Robert L. Bender; Theresa M. Bender, $36,000.

• 4014 Bell St., Michael Greenawalt to Haylor Properties Llc, $24,500.

• 18th St.&Walnut Ave., Michael Martelli; Crystal Martelli to Haylor Properties Llc, $22,000.

• Cayuga Drive, Anthony Zuccaro to Donna Conrad; Walter Conrad, $20,000.

• Pierce Ave.&22nd St., Eric F. Penale to Buffalo Niagara Falls Real Estate Llc, $15,000.

• 713 Townsend Road, Wilmington Trust Co. to Buffalo Niagara Falls Real Estate Llc, $12,500.

• Anthony Zuccaro to Donna Conrad; Walter Conrad, $10,000.

• 2237 Niagara Ave.,HUD to Kendesia May, $8,888.

• 1347 Whitney Ave., Joan Kwong to Ying Kwan, $5,000.

NORTH TONAWANDA

• Wurlitzer Court, John A. Pisarski; Paula S. Pisarski to Amy A. Griggs; David A. Griggs, $170,000.

• Tremont St.&Falconer St., Hollis S. Keisic; Michael S. Brody; Deborah S. Root; Christopher S. Brody; Hollis S. Brody; Deborah S. Brody to Kathleen A. Smith; Michael W. Smith, $154,700.

• Nash Road, Rosemary A. Sperrazza; John J. Sperrazza to Amy L. Schmitt, $132,500.

• Niagara St., Rebecca Mylar; William Mason to David A. Pollina, $128,000.

• Wheatfield St., Mary Wanda Kinder; Joseph M. Kinder to Ashley M. Bardo, $95,400.

• Tremont St.&Spruce St., Thomas J. Meredith; Lauren M. Meredith to Eric A. Mucha, $90,100.

• East Schenck St., Matthew J. Anastasi to Tammy L. Matlock, $80,000.

• 590 Wall St., Charles P. Vishion; Judith E. Vishion to HSBC Bank, $76,399.

• 36 Grant St., Heather Calder; Alexander M. Calder; Ian Calder to Fannie Mae, $69,452.

• Gilmore Ave., Nancy A. McIntyre; Thomas L. McIntyre to Christine M. Jones, $48,000.

• 383 Falconer St.,HUD to Doo W. Sung, $24,500.

• Castlebar Drive, Karen J. Schenk; William G. Young; Raymond J. Young to Paul A. Tipton; Kimberlee C. Tipton, $22,000.

PENDLETON

• 6770 Bear Ridge Road, Ralph Tramposch; Eileen Tramposch to Anthony J. Giessert; Denise L. Giessert, $64,900.

• Creekbend Drive, CL&F Development Llc to Christopher D. Gump; Michele L. Gump, $60,000.

PORTER

• Youngstown-Lockport Road, Gregory P. Davidson; Marilyn J. Davidson to Michael F. Shackelford, $71,020.

• Youngstown-Wilson Road, Nationstar Mortgage Llc to Buffalo Niagara Falls Real Estate Llc, $27,500.

ROYALTON

• 67 St. ate St., Harold E. Williams to Charles A. Barton, $69,000.

SOMERSET

• 8743 Main St., Robert C. Holm; Patricia L. Holm to US Bank, $36,000.

WHEATFIELD

• Lakewood Drive, Vanderbilt Properties Inc. to Thomas J. Phillips, $266,559.

• Trails End Lane, Jennifer G. Haynes; Brian J. Haynes to Prudential Relocation Inc., $208,350.

• Trails End Lane, Prudential Relocation Inc. to David W. Andrews, $208,350.

• Lakeside Drive, Ryan Homes of New York; Nvr Inc. to Lynn S. Reed, $188,615.

• Lake Mead Road, Amy A. Griggs; Amy A. Digati; David A. Griggs to Thomas A. Stefanucci, $143,000.

• Elbert Drive, Kenneth Maciver; Lois Marie Maciver; Lois M. Maciver to Eric W. Howitt, $116,000.

• Nash Road, Rita Meyers; Clifford E. Niethe; Rita Gerber; Dorothy I. Niethe; to Patricia L. Lapaglia, $87,000.

• Knottingwood Drive, Marrano/ Marc Equity Corp. to Ryan Homes of New York; Nvr Inc., $50,000.

• 7024 Lakeside Drive, DS of Wheatfield Llc to Ryan Homes of New York; Nvr Inc., $34,900.

• Ward Road, Zuccari Bros Inc. to Joseph V. Paolini; Natalie A. Paolini, $5,000.

WILSON

• 233 Young St., Mary Elliott Reid; James L. Reid to George E. Bell; Katrina E. Bell, $50,000.

• Wilson-Burt Road&Maple Road, Robert W. Rohring; Rena S. Rohring to Mario J. Basso; Marie A. Basso, $22,000.

• Cleveland Ave., Richard J. Bateman to Joseph Skrlin, $9,144.

• 3494 Palmer Road, Household Finance Realty Corporation of New York to George Falbo; Jean Falbo, $6,000.

Log into MyBuffalo to post a comment